Dear Colleagues,
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in the world. Lipid management is essential to prevent ASCVD. Low-density lipoprotein cholesterol (LDL-C) lowering therapy with statins is the cornerstone for lipid therapy in clinical practice but there are still unmet needs to reduce the risk of ASCVD. It remains unclear as to whether elevated lipoprotein(a) (Lp(a)), elevated triglycerides (TG), and non-HDL LDL-C increase the risk for ASCVD, valvular heart disease, and cardiomyopathies and what the optimal treatment goals for preventing ASCVD, and valvular heart disease should be.
This Special Issue " Lipoproteins and lipids in cardiovascular disease " will collect high-quality original research papers and comprehensive reviews on recent evidence in relation to lipoproteins and lipids and their effects on cardiovascular disease/damage. The topics of interest include, but are not limited to:
Myocardial fibrosis/remodeling
Atherothrombotic disease
Coronary atherosclerosis/coronary artery disease
Cardiomyopathies
Arrhythmias
Cardiovascular Imagining
Genetics
Mechanisms
Biomarkers
Prof. Yu-Sheng Lin
Guest Editor
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Open Access Short CommunicationNovel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in StrokeLayal El-Hajjar, Elena Miranda, Marwan El-Sabban, Jalil DaherRev. Cardiovasc. Med. 2023, 24(12), 354; https://doi.org/10.31083/j.rcm2412354(This article belongs to the Special Issue Lipoproteins and Lipids in Cardiovascular Disease)22Downloads121Views
- Open Access Original ResearchElevated Lipoprotein(a) Levels are Associated with Arterial Stiffness Measured by Cardio-Ankle Vascular Index in Patients Undergoing Peritoneal DialysisPo-Yu Huang, Bang-Gee Hsu, Huei-Jhen Lin, Yu-Li Lin, ... Jen-Pi TsaiRev. Cardiovasc. Med. 2023, 24(11), 322; https://doi.org/10.31083/j.rcm2411322(This article belongs to the Special Issue Lipoproteins and Lipids in Cardiovascular Disease)34Downloads126Views